Clearpoint Non Currrent Assets Other from 2010 to 2025

CLPT Stock  USD 12.42  0.04  0.32%   
Clearpoint Neuro Non Currrent Assets Other yearly trend continues to be comparatively stable with very little volatility. Non Currrent Assets Other will likely drop to about 238.4 K in 2025. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
2011-12-31
Previous Quarter
346 K
Current Value
251 K
Quarterly Volatility
312 K
 
Yuan Drop
 
Covid
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 330 K or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 17.19. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Latest Clearpoint Neuro's Non Currrent Assets Other Growth Pattern

Below is the plot of the Non Currrent Assets Other of Clearpoint Neuro over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Clearpoint Neuro's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other10 Years Trend
Pretty Stable
   Non Currrent Assets Other   
       Timeline  

Clearpoint Non Currrent Assets Other Regression Statistics

Arithmetic Mean639,702
Geometric Mean508,907
Coefficient Of Variation55.23
Mean Deviation288,680
Median648,000
Standard Deviation353,278
Sample Variance124.8B
Range1.1M
R-Value(0.14)
Mean Square Error131B
R-Squared0.02
Significance0.60
Slope(10,567)
Total Sum of Squares1.9T

Clearpoint Non Currrent Assets Other History

2025238.4 K
2024251 K
2023495 K
2022581 K
2021644 K
2020648 K
2019722 K

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Currrent Assets Other251 K238.4 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.